{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Ivosidenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ivosidenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ivosidenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "ivosidenib",
    "trial_2_text": "Ivosidenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Ivosidenib Supplement: 60 participants will take Ivosidenib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Ivosidenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Ivosidenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "78": 0.28528085350990295,
      "87": 0.22857269644737244,
      "123": 0.1852269321680069,
      "189": 0.17866644263267517,
      "188": 0.16405901312828064,
      "173": 0.15209682285785675,
      "20": 0.1495160162448883,
      "177": 0.1436789631843567,
      "9": 0.12371347844600677,
      "17": 0.11685636639595032,
      "46": 0.11682046204805374,
      "200": 0.11469293385744095,
      "21": 0.11417175829410553,
      "64": 0.11317458748817444,
      "67": 0.11055634915828705,
      "37": 0.10571467876434326,
      "350": 0.10270476341247559,
      "68": 0.1018289253115654,
      "228": 0.10102503001689911,
      "29": 0.0977446585893631,
      "49": 0.09679988771677017,
      "239": 0.09568887948989868,
      "2": 0.08920880407094955,
      "14": 0.08666465431451797,
      "27": 0.0855974331498146,
      "179": 0.08531291037797928,
      "243": 0.08483453094959259,
      "79": 0.08352101594209671,
      "38": 0.08275342732667923,
      "77": 0.08021747320890427,
      "30": 0.07701288163661957,
      "104": 0.07626134902238846,
      "147": 0.07474333047866821,
      "126": 0.0745367631316185,
      "61": 0.07450520992279053,
      "139": 0.0738401934504509,
      "5": 0.0737372636795044,
      "151": 0.07367530465126038,
      "193": 0.07295473664999008,
      "396": 0.07283127307891846,
      "114": 0.0721684917807579,
      "131": 0.0701998695731163,
      "86": 0.06936240196228027,
      "76": 0.06897708773612976,
      "180": 0.06810998171567917,
      "276": 0.06775130331516266,
      "72": 0.06646592915058136,
      "85": 0.06612912565469742,
      "261": 0.06582923233509064,
      "441": 0.06427400559186935,
      "28": 0.06304121017456055,
      "282": 0.06239580735564232,
      "116": 0.06103069707751274,
      "122": 0.060343507677316666,
      "35": 0.05844911187887192,
      "194": 0.05657697841525078,
      "269": 0.054520998150110245,
      "191": 0.054415229707956314,
      "97": 0.05359213054180145,
      "18": 0.053477946668863297,
      "204": 0.05321976915001869,
      "355": 0.05246341601014137,
      "102": 0.051621485501527786,
      "249": 0.050703130662441254,
      "341": 0.050445616245269775,
      "101": 0.0487380251288414,
      "33": 0.04810812324285507,
      "466": 0.047675278037786484,
      "96": 0.04747802019119263,
      "75": 0.04679439589381218,
      "164": 0.046647168695926666,
      "69": 0.04614957794547081,
      "253": 0.04575708508491516,
      "186": 0.04511643201112747,
      "288": 0.045093417167663574,
      "286": 0.044758498668670654,
      "36": 0.044552817940711975,
      "268": 0.04429071024060249,
      "82": 0.04357348755002022,
      "454": 0.042500484734773636,
      "212": 0.041147083044052124,
      "361": 0.04072403162717819,
      "142": 0.04022146388888359,
      "31": 0.0400090292096138,
      "15": 0.03877467289566994,
      "508": 0.03876608982682228,
      "92": 0.03853626176714897,
      "163": 0.038536086678504944,
      "121": 0.037591416388750076,
      "100": 0.03615567460656166,
      "256": 0.036085791885852814,
      "257": 0.035964496433734894,
      "144": 0.035816531628370285,
      "130": 0.03569423034787178,
      "382": 0.03539137542247772,
      "98": 0.035183731466531754,
      "136": 0.03479216247797012,
      "132": 0.03472568094730377,
      "494": 0.0345526747405529,
      "456": 0.03443342447280884
    },
    "trial_2_ae": {
      "78": 0.28528085350990295,
      "87": 0.22857269644737244,
      "123": 0.1852269321680069,
      "189": 0.17866644263267517,
      "188": 0.16405901312828064,
      "173": 0.15209682285785675,
      "20": 0.1495160162448883,
      "177": 0.1436789631843567,
      "9": 0.12371347844600677,
      "17": 0.11685636639595032,
      "46": 0.11682046204805374,
      "200": 0.11469293385744095,
      "21": 0.11417175829410553,
      "64": 0.11317458748817444,
      "67": 0.11055634915828705,
      "37": 0.10571467876434326,
      "350": 0.10270476341247559,
      "68": 0.1018289253115654,
      "228": 0.10102503001689911,
      "29": 0.0977446585893631,
      "49": 0.09679988771677017,
      "239": 0.09568887948989868,
      "2": 0.08920880407094955,
      "14": 0.08666465431451797,
      "27": 0.0855974331498146,
      "179": 0.08531291037797928,
      "243": 0.08483453094959259,
      "79": 0.08352101594209671,
      "38": 0.08275342732667923,
      "77": 0.08021747320890427,
      "30": 0.07701288163661957,
      "104": 0.07626134902238846,
      "147": 0.07474333047866821,
      "126": 0.0745367631316185,
      "61": 0.07450520992279053,
      "139": 0.0738401934504509,
      "5": 0.0737372636795044,
      "151": 0.07367530465126038,
      "193": 0.07295473664999008,
      "396": 0.07283127307891846,
      "114": 0.0721684917807579,
      "131": 0.0701998695731163,
      "86": 0.06936240196228027,
      "76": 0.06897708773612976,
      "180": 0.06810998171567917,
      "276": 0.06775130331516266,
      "72": 0.06646592915058136,
      "85": 0.06612912565469742,
      "261": 0.06582923233509064,
      "441": 0.06427400559186935,
      "28": 0.06304121017456055,
      "282": 0.06239580735564232,
      "116": 0.06103069707751274,
      "122": 0.060343507677316666,
      "35": 0.05844911187887192,
      "194": 0.05657697841525078,
      "269": 0.054520998150110245,
      "191": 0.054415229707956314,
      "97": 0.05359213054180145,
      "18": 0.053477946668863297,
      "204": 0.05321976915001869,
      "355": 0.05246341601014137,
      "102": 0.051621485501527786,
      "249": 0.050703130662441254,
      "341": 0.050445616245269775,
      "101": 0.0487380251288414,
      "33": 0.04810812324285507,
      "466": 0.047675278037786484,
      "96": 0.04747802019119263,
      "75": 0.04679439589381218,
      "164": 0.046647168695926666,
      "69": 0.04614957794547081,
      "253": 0.04575708508491516,
      "186": 0.04511643201112747,
      "288": 0.045093417167663574,
      "286": 0.044758498668670654,
      "36": 0.044552817940711975,
      "268": 0.04429071024060249,
      "82": 0.04357348755002022,
      "454": 0.042500484734773636,
      "212": 0.041147083044052124,
      "361": 0.04072403162717819,
      "142": 0.04022146388888359,
      "31": 0.0400090292096138,
      "15": 0.03877467289566994,
      "508": 0.03876608982682228,
      "92": 0.03853626176714897,
      "163": 0.038536086678504944,
      "121": 0.037591416388750076,
      "100": 0.03615567460656166,
      "256": 0.036085791885852814,
      "257": 0.035964496433734894,
      "144": 0.035816531628370285,
      "130": 0.03569423034787178,
      "382": 0.03539137542247772,
      "98": 0.035183731466531754,
      "136": 0.03479216247797012,
      "132": 0.03472568094730377,
      "494": 0.0345526747405529,
      "456": 0.03443342447280884
    }
  },
  "safety": {
    "trial_1_safety": 0.4486110806465149,
    "trial_2_safety": 0.4486110806465149
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47697916626930237
  }
}